Assessment of Knowledge Regarding Risks and Benefits of the Use of Non-Vitamin K Antagonist Oral Anticoagulants

Assessment of Knowledge Regarding Risks and Benefits of the Use of Non-Vitamin K Antagonist Oral Anticoagulants

Background: Non-vitamin K antagonist oral anticoagulants (NOAC) have replaced vitamin K antagonist (VKA) oral anticoagulants as the first-line treatment option for stroke prevention in high-risk patients with atrial fibrillation. With VKA therapy, disease and treatment-related knowledge is associate...

Full description

Bibliographic Details
Main Authors: Jose Raul Valery, Ahmad Marar, George Pujalte, Cynthia Ward, Yousif M. Abdelmoneim, Patrick J. Fitzgerald, Edson Mwakyanjala, Dana M. Harris, Loren Murray, Michael G. Heckman, Launia J. White, Fernando Stancampiano
Format: Article
Language:English
Published: SAGE Publishing 2022-08-01
Series:Journal of Primary Care & Community Health
Online Access:https://doi.org/10.1177/21501319221118806

Internet

https://doi.org/10.1177/21501319221118806

Similar Items